higher competition. The company recorded revenue from services of 579.03 million Baht which increased from the last year totaling 431.89 million Baht or 293.52% due to the expansion of construction

by Baht 11.33 million or 2.40 % due to the Medical personal expenses increased from the expansion of the subsidiaries. 3.Administrative expenses increased by Baht 29.82 million or 30.84 % due to the

through this channel will help facilitate their business expansion and development as well as foster their competitive edge at domestic and international levels. To this end, more jobs would be created and

decreased by Baht 18 million or 10% from Q1/2017 due to lower business development cost. Finance costs In Q1/2018, finance costs were Baht 119 million, increased by Baht 29 million or 32% from Q4/2017 and

, The Company’s strategies such as increasing more specialty cilinics, medical instruments and expanding into new market so as to drive a sustainable growth Cost of Hospital Operations The costs of

startup of new plant in Jiangsu for example rental expense and product development cost etc. 3. The consolidated net loss was 0.39%, last year’s net profit was 0.88%, mostly caused by the reduction in gross

% from last year mainly due to employee-related expenses, depreciation, development cost writeoff and Specific Business Tax. Share of profit from investments in associated companies For the first nine

higher production cost in accordance with higher sales volume and from machines' maintenance and development cost, and factory supplies. For the 2d quarter of 2A17 , the selling and administrative expenses

-related expenses, depreciation and development cost writeoff. Share of profit from investments in associated companies For the first half of 2019, the Company and its subsidiaries reported share of profit

by Baht 444.73 million or 22.41% from last year mainly due to employee-related expenses, depreciation, development cost writeoff and Specific Business Tax. Share of profit from investments in